Mechanism Underlying Counterregulation of Autoimmune Diabetes by IL-4

Slides:



Advertisements
Similar presentations
Third-party Mesenchymal Stem Cells Improved Human Islet Transplantation in a Humanized Diabetic Mouse Model  Hao Wu, Di Wen, Ram I Mahato  Molecular Therapy 
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Pancreatic Lymph Node-Derived CD4+CD25+ Treg Cells
Volume 31, Issue 4, Pages (October 2009)
Exacerbated colitis associated with elevated levels of activated CD4+ T cells in TCRα chain transgenic mice  Immo Prinz, Uwe Klemm, Stefan H.E. Kaufmann,
Initial T Cell Receptor Transgenic Cell Precursor Frequency Dictates Critical Aspects of the CD8+ T Cell Response to Infection  Vladimir P. Badovinac,
Volume 25, Issue 3, Pages (September 2006)
Volume 13, Issue 6, Pages (November 2015)
Effects and Regulation of Autoreactive CD8+ T Cells in a Transgenic Mouse Model of Autoimmune Hepatitis  Mario Zierden, Elisabeth Kühnen, Margarete Odenthal,
Activated glycoprotein A repetitions predominant (GARP)–expressing regulatory T cells inhibit allergen-induced intestinal inflammation in humanized mice 
Volume 15, Issue 1, Pages (January 2007)
Volume 8, Issue 5, Pages (May 2017)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 24, Issue 5, Pages (November 2013)
Volume 19, Issue 6, Pages (December 2003)
Volume 18, Issue 5, Pages (May 2003)
Cellular Mechanisms of Fatal Early-Onset Autoimmunity in Mice with the T Cell-Specific Targeting of Transforming Growth Factor-β Receptor  Julien C. Marie,
Ananda W Goldrath, Michael J Bevan  Immunity 
Volume 13, Issue 6, Pages (June 2008)
Local Expression of TNFα in Neonatal NOD Mice Promotes Diabetes by Enhancing Presentation of Islet Antigens  E.Allison Green, Elizabeth E. Eynon, Richard.
Thomas R Malek, Aixin Yu, Vladimir Vincek, Paul Scibelli, Lin Kong 
Volume 134, Issue 3, Pages (March 2008)
Volume 25, Issue 5, Pages (November 2006)
Mechanism Underlying Counterregulation of Autoimmune Diabetes by IL-4
Volume 8, Issue 5, Pages (May 1998)
Volume 28, Issue 5, Pages (May 2008)
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice  Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Lymphoproliferation in CTLA-4–Deficient Mice Is Mediated by Costimulation-Dependent Activation of CD4+ T Cells  Cynthia A Chambers, Timothy J Sullivan,
Volume 36, Issue 1, Pages (January 2012)
Volume 14, Issue 1, Pages (January 2001)
E.Allison Green, Richard A Flavell  Immunity 
Volume 16, Issue 3, Pages (March 2002)
Volume 15, Issue 1, Pages (July 2001)
Volume 29, Issue 2, Pages (August 2008)
NKG2D Blockade Prevents Autoimmune Diabetes in NOD Mice
Volume 12, Issue 5, Pages (May 2000)
Volume 16, Issue 5, Pages (May 2002)
Volume 16, Issue 2, Pages (February 2002)
Volume 5, Issue 3, Pages (September 1996)
Volume 33, Issue 4, Pages (October 2010)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Volume 43, Issue 2, Pages (August 2015)
Volume 34, Issue 4, Pages (April 2011)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 35, Issue 2, Pages (August 2011)
Cecile King, Alex Ilic, Kersten Koelsch, Nora Sarvetnick  Cell 
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Volume 17, Issue 5, Pages (November 2002)
Volume 31, Issue 4, Pages (October 2009)
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
Volume 41, Issue 4, Pages (October 2014)
Sibylle von Vietinghoff, Hui Ouyang, Klaus Ley  Kidney International 
Volume 28, Issue 5, Pages (May 2008)
Protective Regulatory T Cell Generation in Autoimmune Diabetes by DNA Covaccination with Islet Antigens and a Selective CTLA-4 Ligand  Yelena Glinka,
NOX-deficient NOD-Ncf1m1J immune system has a reduced capacity to transfer type 1 diabetes (T1D) to immune-deficient hosts. NOX-deficient NOD-Ncf1m1J immune.
Volume 13, Issue 6, Pages (November 2015)
T1D is reduced in CT-treated NOD mice.
Volume 13, Issue 1, Pages (July 2000)
Volume 9, Issue 5, Pages (November 1998)
Volume 11, Issue 4, Pages (October 1999)
Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Thymocyte Glucocorticoid Resistance Alters Positive Selection and Inhibits Autoimmunity and Lymphoproliferative Disease in MRL-lpr/lprMice  Eva Tolosa,
Volume 7, Issue 4, Pages (October 1997)
Volume 25, Issue 3, Pages (September 2006)
Volume 25, Issue 4, Pages (October 2006)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Mechanism Underlying Counterregulation of Autoimmune Diabetes by IL-4 Regula Mueller, Linda M Bradley, Troy Krahl, Nora Sarvetnick  Immunity  Volume 7, Issue 3, Pages 411-418 (September 1997) DOI: 10.1016/S1074-7613(00)80362-3

Figure 1 T Cell Proliferative Responses of NOD-IL-4 Splenocytes In vitro proliferation of splenocytes from NOD-IL-4 mice (open bars) and their non-tg littermates (hatched bars) in response to stimulation with irradiated whole islet cells from NOD mice and with ConA. Proliferation was determined after 4 days of culture by incorporation of [3H]thymidine. Immunity 1997 7, 411-418DOI: (10.1016/S1074-7613(00)80362-3)

Figure 2 Cumulative Incidence of Diabetes in NOD-scid Mice Following IV Injection of Splenocytes Recipients with two consecutive blood glucose values greater than 250 mg/dl in weekly tests were considered diabetic. (A) Donor splenocytes were isolated from either NOD-IL-4 females (triangles) or from their diabetic NOD female littermates (squares). (B) Donor splenocytes were isolated from diabetic NOD females and their NOD-IL-4 female littermates and injected at a 1:2 ratio (triangles). Results from diabetic NOD females (squares) from (A) are given for comparison. Immunity 1997 7, 411-418DOI: (10.1016/S1074-7613(00)80362-3)

Figure 3 Insulitic Potential of Splenocytes after In Vitro Activation with ConA Splenocytes were isolated from 8-week-old NOD-IL-4 mice and their non-tg littermates and stimulated in vitro with ConA for 48 hr. Cells were subsequently injected IV into NOD-scid mice. Three weeks later, islets of recipients were scored for the presence of insulitis (filled bars), periinsulitis (hatched bars), or absence of inflammation (open bars). Immunity 1997 7, 411-418DOI: (10.1016/S1074-7613(00)80362-3)

Figure 4 Cumulative Incidence of Diabetes after CY Injections into NOD-IL-4 Males and Their Male Non-tg Littermates Open squares, NOD-IL-4 males; filled squares, male non-tg littermates. Mice were treated with CY on days 0 and 14, and blood glucose values were determined weekly. Mice with two consecutive blood glucose values greater than 250 mg/dl were considered diabetic. Immunity 1997 7, 411-418DOI: (10.1016/S1074-7613(00)80362-3)

Figure 5 Cell Surface Expression of Differentiation and Activation Markers on BDC2.5 T Cells Spleen cells from BDC2.5 mice (left), aged 8 weeks, or NOD mice (right), aged 10 weeks, were stained for the indicated markers. (A) Percentages of CD4+ T cells (y axis) and CD8+ T cells (x axis). (B) Expression of Vβ4 by CD4+ T cells (top) and CD8+ T cells (bottom). (C) Markers that are affected by priming. Values for L-selectin and CD25 are determined by comparison to the isotype controls shown. Values for CD44 and CD45RB are for high-expressing cells. Left, Vβ4+ T cells from BDC2.5 mice; right, CD4+ T cells from NOD mice. Immunity 1997 7, 411-418DOI: (10.1016/S1074-7613(00)80362-3)

Figure 6 Cumulative Incidence of Diabetes among Female and Male Offspring from NOD-IL-4 × BDC2.5 Breedings (A) Female offspring; (B) male offspring. Blood glucose values were determined twice a month in non-tg (squares), IL-4+ single tg (circles), BDC2.5+ single tg (triangles), and IL-4+/BDC2.5+ double tg (diamonds) mice. Mice were considered diabetic if two consecutive blood glucose values greater than 250 mg/dl were observed. Immunity 1997 7, 411-418DOI: (10.1016/S1074-7613(00)80362-3)

Figure 7 Histological Analysis of Pancreata from BDC2.5+ Single Tg and IL-4+/BDC2.5+ Double Tg Mice (A) Pancreas from a BDC2.5+ tg mouse, hematoxylin and eosin (H+E) stained. Note the extensive inflammatory infiltrate in the pancreas. (B) Pancreas from a BDC2.5+ tg mouse, higher magnification, H+E stained. Note the substantial remaining islet cell mass. (C) Pancreas from a BDC2.5+ tg mouse, immunostained for insulin using DAB as a chromagen. Note the substantial islet cells mass stained positively for insulin (brown-red color). (D) Pancreas from an IL-4+/BDC2.5+ double tg mouse, H+E stained. Note the extensive infiltrate. (E) Pancreas from an IL-4+/BDC2.5+ double tg mouse, higher magnification, H+E stained. Note extensive infiltrate and the absence of discernible islet structures. (F) Pancreas from an IL-4+/BDC2.5+ double tg mouse, immunostained for insulin using DAB as a chromagen. Note the lack of islet structures and paucity of insulin-producing cells. (G) Pancreas from a BDC2.5+ tg mouse stained with anti-CD4. Note the extensive infiltration of CD4+ T cells. (H) Pancreas from a BDC2.5+ tg mouse stained with anti-CD8. Note the extensive infiltration of CD8+ T cells. (I) Pancreas from a BDC2.5+ tg mouse stained with anti-IL-2 receptor. Note the lack of activation of infiltrating cells. (J) Pancreas from an IL-4+/BDC2.5+ double tg mouse stained with anti-CD4. Note the extensive infiltration of CD4+ T cells. (K) Pancreas from an IL-4+/BDC2.5+ double tg mouse stained with anti-CD8. Note the extensive infiltration of CD8+ T cells. (L) Pancreas from an IL-4+/BDC2.5+ double tg mouse stained with anti-IL-2 receptor. Note the high proportion of activated infiltrating cells. Immunity 1997 7, 411-418DOI: (10.1016/S1074-7613(00)80362-3)

Figure 8 Cumulative Incidence of Diabetes after Splenocyte Transfer into NOD-scid Mice Splenocytes were isolated from BDC2.5+ single tg mice and immediately transferred (circles) or first stimulated in vitro with ConA for 48 hr and then transferred (squares). Splenocytes were also isolated from IL-4+/BDC2.5+ double tg mice and immediately transferred (diamonds). Blood glucose values in recipients were determined once a week. Mice were considered diabetic if two consecutive blood glucose values greater than 250 mg/dl were observed. Immunity 1997 7, 411-418DOI: (10.1016/S1074-7613(00)80362-3)